RIJUVEN MEDICARE INDIA PRIVATE LIMITED

In their own words

RIJUVEN is a deep-tech healthcare company developing innovative medical devices, digital healthcare solutions, and cloud-based care platforms. Its solutions - including the patented, US FDA-cleared CardioSleeve® and Clinic in a Bag® - support early disease detection, point-of-care diagnostics, telemedicine, and remote patient monitoring, with a focus on expanding affordable, high-quality healthcare to rural, remote, and underserved population. (1). Most diseases have screening tests before the gold-standard, but Heart Failure lacks one, leaving millions worldwide undiagnosed leading to chronic heart failure and multi-organ dysfunction. Rijuven bridges this critical gap through its innovative medical device - CardioSleeve®. CardioSleeve® is the world's first patented, US FDA-cleared stethoscope attachment that transforms any conventional stethoscope into an intelligent, comprehensive point-of-care cardiac screening tool, delivering multiple cardiac assessments in under 30 secs/test. · 3-lead ECG · Digital Heart Sound analysis · Cardiac Function (Echo-EF%) assessment · Early Heart Failure Screening (2). Across the world, healthcare systems are strained by shortages of healthcare professionals, inadequate infrastructure, long distances to healthcare facilities, and escalating costs of managing diseases. The common thread underlying these challenges is the lack of early disease detection. Rijuven bridges this critical gap through its innovative healthcare platform - Clinic in a Bag® (A CLINIC WITHOUT WALLS). Clinic-in-a-Bag® transforms any location into a fully functional primary healthcare clinic. By integrating medical devices, point-of-care laboratory testing, mobile applications, and cloud-based patient management into a single portable platform, it enables healthcare workers to deliver comprehensive healthcare with instant reports.Together, these technologies power a unified ecosystem for: · Preventive healthcare · Primary healthcare at any point of care: Satellite clinics or Pop-up clinics · Telemedicine · Remote patient monitoring The company's technology has been validated through successful government-led regulatory (Patents, FDA), Clinical studies and Pilot deployments. Rijuven's healthcare innovations have demonstrated strong clinical performance and earned prestigious recognition internationally - selected as one of the top two finalists among 200 global participants in 'Philips Innovation Challenge', and as the Winner in 'AP MedTech Innovation Challenge 2026' (Remote Care & Telemedicine category) among 297 participants from across India. ******

Written by the company on its public Startup India profile. Not verified by us.